Leidos Vice President of Global Health Exploration says there is potential spin-off in biotechnology
Jim Pannucci, vice president of global health research at Leidos Holdings Inc [NYSE: LDOS], sat down with Proactive at the BIO Investor Forum in San Francisco.
No comments:
Post a Comment